Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.J., January 21, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen’s 25-year commitment to make HIV history. In the U.S., ViiV Healthcare is the marketing authorization holder for CABENUVA.C...
Source: Johnson and Johnson - January 22, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!”
I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed.
This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news
mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!”
I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed.
This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Special Topics)
Source: JEMS Special Topics - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Operations)
Source: JEMS Operations - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Latest News)
Source: JEMS Latest News - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Administration and Leadership)
Source: JEMS Administration and Leadership - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine
___
(c)2021 the Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com
Distributed by Tribune Content Agency, LLC.
The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Patient Care)
Source: JEMS Patient Care - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news
Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news
The Ambulance Science Podcast: Make Up Your Own Mind About the Vaccine
Get every episode of The Ambulance Science Podcast by subscribing to Apple Podcasts or Google Podcasts.
Where I’m coming from (compared to most of my colleagues):
Master’s in Public Health with a concentration in Health Policy from Yale Medical School.FT Faculty at GWU School of Medicine & Southern Connecticut State University MPH Program, and long-time adjunct faculty at NYMC MPH program in Health Policy.Assistant Commissioner of Health at the NYC Department of Health & Mental Hygiene during the first SARS outbreak.Served as State EMS Director, Consultant to Public Health ...
Source: JEMS Special Topics - December 14, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Podcasts Ambulance Science Source Type: news
NIDCR's Winter 2020 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Winter 2020 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities
NIH/HHS News
Funding Notices
Science Advances
Subscribe to NICDR News
Grantee News
NIDCR News
NIDCR Welcomes New Director Rena D’Souza
Rena N. D’Souza, DDS, MS, PhD, was sworn in as the director of NIDCR by NIH Director Francis S. Collins, MD, PhD, on October 13. Prior to joining NIH, Dr. D’Souza was the assistant vice president for academic affairs and education for health sciences at the Un...
Source: NIDCR Science News - December 4, 2020 Category: Dentistry Source Type: news
Health and care heroes honoured in parliamentary awards
Doctors and nurses working to combat Hepatitis C in the homeless during the pandemic, the team behind the UK ’s first virtual reality lung rehabilitation programme launched this year and the research team working on the COVID-19 vaccine have all been recognised in the regional round of the NHS parliamentary awards. (Source: NHS Networks)
Source: NHS Networks - November 24, 2020 Category: UK Health Source Type: news
New video: See how strong IP protections lead to stronger treatments for patients
Intellectual property (IP) protections, including patents, are the foundation for biopharmaceutical innovation and the development of new treatments, cures and vaccines for patients. A strong IP system is what has allowed the American biopharmaceutical industry to become the world leader in new medicine development and has allowed us to make unprecedented strides in treating everything from acute leukemia to hepatitis C and more. (Source: The Catalyst)
Source: The Catalyst - November 9, 2020 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Intellectual Property IP Explained Source Type: news
A promising discovery could lead to better treatment for Hepatitis C
(Institut national de la recherche scientifique - INRS) Virologists at Institut national de la recherche scientifique (INRS) have identified a critical role played by a cellular protein in the progression of Hepatitis C virus infection, paving the way for more effective treatment. No vaccine currently exists for Hepatitis C virus infection, which affects more than 130 million people worldwide and nearly 250,000 Canadians. Antivirals exist but are expensive and not readily available in developing countries, where the disease is most prevalent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 22, 2020 Category: Infectious Diseases Source Type: news
